Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/30367
Title: | Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction |
Authors: | Wood, GK Sargent, BF Ahmad, Z-U-A Tharmaratnam, K Dunai, C Egbe, FN Martin, NH Facer, B Pendered, SL Rogers, HC Hübel, C van Wamelen, DJ Bethlehem, RAI Giunchiglia, V Hellyer, PJ Trender, W Kalsi, G Needham, E Easton, A Jackson, TA Cunningham, C Upthegrove, R Pollak, TA Hotopf, M Solomon, T Pett, SL Shaw, PJ Wood, N Harrison, NA Miller, KL Jezzard, P Williams, G Duff, EP Williams, S Zelaya, F Smith, SM Keller, S Broome, M Kingston, N Husain, M Vincent, A Bradley, J Chinnery, P Menon, DK Aggleton, JP Nicholson, TR Taylor, JP David, AS Carson, A Bullmore, E Breen, G Hampshire, A Zandi, MS Wong, SH Venneri, A Veenith, T Underwood, J Thomson, E Thomas, RH Tamborska, A Taams, L Smith, J Smith, CJ Singh, B Sieradzki, A Shil, RSK Semple, S Seed, AW Sawcer, SJ Samuel, M Salman, RAS Rota, S Roberts, A Peacock, S Patel, A Palmos, A Ostermann, M Orazulume, O O’Malley, R Nicholas, N Newcombe, V Nair, A Mulholland, C Morris, CM Monssen, D McIntosh, AM McIlwaine, R McKeever, S McGlinchey, E McDonnell, G Mansoori, P Madarshahian, D |
Keywords: | chronic inflammation;encephalopathy;outcomes research;predictive markers;viral infection |
Issue Date: | 23-Sep-2024 |
Publisher: | Springer Nature |
Citation: | Wood, K. et al. on behalf of the COVID-CNS Consortium (2024) 'Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction', Nature Medicine, 0 (ahead of print), pp. 1 - 25. doi: 10.1038/s41591-024-03309-8. |
Abstract: | The spectrum, pathophysiology and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We report the 1-year cognitive, serum biomarker and neuroimaging findings from a prospective, national study of cognition in 351 COVID-19 patients who required hospitalization, compared with 2,927 normative matched controls. Cognitive deficits were global, associated with elevated brain injury markers and reduced anterior cingulate cortex volume 1 year after COVID-19. Severity of the initial infective insult, postacute psychiatric symptoms and a history of encephalopathy were associated with the greatest deficits. There was strong concordance between subjective and objective cognitive deficits. Longitudinal follow-up in 106 patients demonstrated a trend toward recovery. Together, these findings support the hypothesis that brain injury in moderate to severe COVID-19 may be immune-mediated, and should guide the development of therapeutic strategies. |
Description: | Data availability:
Individual-level data and samples from the COVID-Clinical Neuroscience Study are available for collaborative research by application through the NIHR BioResource Data Access Committee https://bioresource.nihr.ac.uk/using-our-bioresource/apply-for-bioresource-data-access/. The Committee decide on academic applications, with escalation to the NIHR BioResource Steering Committee for contentious applications, and/or applications from industry. Participants in the NIHR BioResource have all consented to the sharing of de-identified data with bona fide researchers worldwide, for research in the public interest. There are limits to these consents both by expectation and legal—some datasets may not be shared beyond a safe setting in the UK. The Data Access Committee aim to process data-only requests as quickly as possible and meet fortnightly to consider applications. Once approved, timeframes for data availability vary from 2 weeks to 6 months depending on the nature of the data requested. Code availability: Code is publicly available via https://github.com/tnggroup/covidcns. Extended data are available online at: https://www.nature.com/articles/s41591-024-03309-8#Sec24 . Supplementary information is available online at: https://www.nature.com/articles/s41591-024-03309-8#Sec25 . |
URI: | https://bura.brunel.ac.uk/handle/2438/30367 |
DOI: | https://doi.org/10.1038/s41591-024-03309-8 |
ISSN: | 1078-8956 |
Other Identifiers: | ORCiD: Greta K. Wood https://orcid.org/0000-0001-6098-2331 ORCiD: Brendan F. Sargent https://orcid.org/0000-0003-2262-7755 ORCiD: Zain-Ul-Abideen Ahmad https://orcid.org/0000-0002-6940-8851 ORCiD: Kukatharmini Tharmaratnam https://orcid.org/0000-0002-8255-9822 ORCiD: Benedict D. Michael https://orcid.org/0000-0002-8693-8926 ORCiD: Annalena Venneri https://orcid.org/0000-0002-9488-2301 |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © The Author(s) 2024. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. | 4.51 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License